Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 8(10): e77516, 2013.
Article in English | MEDLINE | ID: mdl-24143239

ABSTRACT

BACKGROUND: Insulin-like growth factor binding protein-3 (IGFBP-3) is a multifunctional molecule which is closely related to cell growth, apoptosis, angiogenesis, metabolism and senescence. It combines with insulin-like growth factor-I (IGF-I) to form a complex (IGF-I/IGFBP-3) that can treat growth hormone insensitivity syndrome (GHIS) and reduce insulin requirement in patients with diabetes. IGFBP-3 alone has been shown to have anti-proliferation effect on numerous cancer cells. METHODOLOGY/PRINCIPAL FINDINGS: We reported here an expression method to produce functional recombinant human IGFBP-3 (rhIGFBP-3) in transgenic rice grains. Protein sorting sequences, signal peptide and endoplasmic reticulum retention tetrapeptide (KDEL) were included in constructs for enhancing rhIGFBP-3 expression. Western blot analysis showed that only the constructs with signal peptide were successfully expressed in transgenic rice grains. Both rhIGFBP-3 proteins, with or without KDEL sorting sequence inhibited the growth of MCF-7 human breast cancer cells (65.76 ± 1.72% vs 45.00 ± 0.86%, p < 0.05; 50.84 ± 1.97% vs 45.00 ± 0.86%, p < 0.01 respectively) and HT-29 colon cancer cells (65.14 ± 3.84% vs 18.01 ± 13.81%, p < 0.05 and 54.7 ± 9.44% vs 18.01 ± 13.81%, p < 0.05 respectively) when compared with wild type rice. CONCLUSION/SIGNIFICANCE: These findings demonstrated the feasibility of producing biological active rhIGFBP-3 in rice using a transgenic approach, which will definitely encourage more research on the therapeutic use of hIGFBP-3 in future.


Subject(s)
Breast Neoplasms/pathology , Colonic Neoplasms/pathology , Insulin-Like Growth Factor Binding Protein 3/biosynthesis , Insulin-Like Growth Factor Binding Protein 3/pharmacology , Oryza/genetics , Recombinant Proteins/biosynthesis , Recombinant Proteins/pharmacology , Cell Proliferation/drug effects , Glycosylation , HT29 Cells , Humans , Insulin-Like Growth Factor Binding Protein 3/genetics , Insulin-Like Growth Factor Binding Protein 3/metabolism , MCF-7 Cells , Plants, Genetically Modified , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
2.
Mol Cell Endocrinol ; 365(1): 64-74, 2013 Jan 05.
Article in English | MEDLINE | ID: mdl-22996137

ABSTRACT

Both microtubule and actin are required for insulin-induced glucose uptake. However, the roles of these two cytoskeletons and their relationship in insulin action still remain unclear. In this work, we examined the morphological change of microtubule/actin and their involvement in insulin signal transduction using rat skeletal muscle cells. Insulin rapidly led to microtubule clustering from ventral to dorsal surface of the cell. Microtubule filaments were rearranged to create space where new actin structures formed. Disruption of microtubule prevented insulin-induced actin remodeling and distal insulin signal transduction, with reduction in surface glucose transporter isoform 4 (GLUT4) and glucose uptake. Though microtubule mediated actin remodeling through PKCζ, reorganization of microtubule depended on tyrosine phosphorylation of insulin receptor, the mechanism is different from insulin-induced actin remodeling, which relied on the activity of PI3-kinase and PKCζ. We propose that microtubule network is required for insulin-induced signal transduction and actin remodeling in skeletal muscle cells.


Subject(s)
Actin Cytoskeleton/metabolism , Glucose Transporter Type 4/metabolism , Insulin/metabolism , Microtubules/metabolism , Myoblasts, Skeletal/metabolism , Receptor, Insulin/metabolism , Signal Transduction , Animals , Biological Transport , Cell Line , Cell Membrane/metabolism , Cell Polarity , Glucose/metabolism , Kinetics , Myoblasts, Skeletal/cytology , Phosphatidylinositol 3-Kinase/metabolism , Phosphorylation , Protein Kinase C/metabolism , Protein Processing, Post-Translational , Protein Transport , Rats
3.
Plant Biotechnol J ; 10(3): 353-62, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22145600

ABSTRACT

A high-amylose rice with 64.8% amylose content (AC) was developed by transgenic inhibition of two isoforms of starch branching enzyme (SBE), SBEI and SBEIIb, in an indica rice cultivar. The expression of SBEI and SBEIIb was completely inhibited in the transgenic line, whereas the expression of granule-bound starch synthase was normal. Compared with wild-type rice, drastic reductions in both SBEs in the transgenic rice increased apparent AC in flour from 27.2% to 64.8%, resistant starch (RS) content from 0% to 14.6% and total dietary fibre (TDF) from 6.8% to 15.2%. Elevated AC increased the proportion of long unit chains in amylopectin and increased onset gelatinization temperature and resistance to alkaline digestion; however, kernel weight was decreased. A rat feeding trial indicated that consumption of high-amylose rice decreased body weight gain significantly (P < 0.01); increased faecal mass, faecal moisture and short-chain fatty acids; and lowered the faecal pH. An acute oral rice tolerance test revealed that the high-amylose rice had a positive effect on lowering the blood glucose response in diabetic Zucker fatty rats. This novel rice with its high AC, RS and TDF offers potential benefits for its use in foods and in industrial applications.


Subject(s)
Amylose/metabolism , Diabetes Mellitus/diet therapy , Food, Genetically Modified , Oryza/metabolism , 1,4-alpha-Glucan Branching Enzyme/genetics , 1,4-alpha-Glucan Branching Enzyme/metabolism , Amylopectin/metabolism , Amylose/genetics , Animals , Blood Glucose/metabolism , Diet , Dietary Carbohydrates/administration & dosage , Dietary Carbohydrates/therapeutic use , Dietary Fiber/metabolism , Endosperm/genetics , Endosperm/metabolism , Enzyme Stability , Feces , Female , Glucose Tolerance Test/methods , Hydrogen-Ion Concentration , Male , Oryza/genetics , Plant Proteins/genetics , Plant Proteins/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Rats , Rats, Sprague-Dawley , Rats, Zucker , Starch Synthase/genetics , Starch Synthase/metabolism , Weight Loss
4.
Cell Signal ; 22(10): 1513-22, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20570724

ABSTRACT

Insulin and AMP-activated protein kinase (AMPK) signal pathways are involved in the regulation of glucose uptake. The integration of signals between these two pathways to maintain glucose homeostasis remains elusive. In this work, stimulation of insulin and berberine conferred a glucose uptake or surface glucose transporter 4 (GLUT4) translocation that was less than simple summation of their effects in insulin-sensitive muscle cells. Using specific inhibitors to key kinases of both pathways and PKCzeta small interference RNA, protein kinase C zeta (PKCzeta) was found to regulate insulin-stimulated protein kinase B (PKB) activation and inhibit AMPK activity on dorsal cell surface. In the presence of berberine, PKCzeta controlled AMPK activation and AMPK blocked PKB activity in perinuclear region. The inhibition effect of PKCzeta on AMPK activation or the arrestment of PKB activity by AMPK still existed in basal condition. These results suggest that there is antagonistic regulation between insulin and AMPK signal pathways, which is mediated by the switch roles of PKCzeta.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Glucose/metabolism , Insulin/pharmacology , Muscle Fibers, Skeletal/enzymology , Protein Kinase C/physiology , Signal Transduction , AMP-Activated Protein Kinases/antagonists & inhibitors , Animals , Berberine/pharmacology , Biological Transport , Cell Line , Enzyme Inhibitors/pharmacology , Muscle Fibers, Skeletal/drug effects , Protein Kinase C/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/metabolism , Rats , Signal Transduction/drug effects
5.
Mol Cell Endocrinol ; 317(1-2): 148-53, 2010 Apr 12.
Article in English | MEDLINE | ID: mdl-20036710

ABSTRACT

Berberine has been shown to have insulin-sensitizing effect, but the molecular mechanism underlying remains elusive. In this work, we investigated the effect of berberine on insulin-induced signal transduction and glucose uptake in both insulin-sensitive and insulin-resistant rat skeletal muscle cells. Berberine increased the activity of AMPK and PKCzeta and AS160 phosphorylation in normal cells, but had little effect on PKB activation. In insulin-resistant state, berberine exhibited synergistic effect on insulin-induced glucose uptake and GLUT4 translocation. Berberine improved insulin-induced tyrosine-phosphorylation of IRS-1 and the recruitment of p85 to IRS-1. These changes were accompanied by enhancement in insulin-induced PKCzeta and PKB activity and actin remodeling. The ameliorated insulin signal transduction was related to the inhibition of mTOR by berberine, which attenuated serine-phosphorylation of IRS-1. These results suggest that berberine may overcome insulin resistance via modulating key molecules in insulin signaling pathway, leading to increased glucose uptake in insulin-resistant cells.


Subject(s)
Berberine/pharmacology , Insulin Resistance , Insulin/metabolism , Muscle Cells/drug effects , Muscle Cells/metabolism , Signal Transduction/drug effects , Actins , Animals , Glucose/metabolism , Glucose Transporter Type 4/metabolism , Mice , Muscle Cells/enzymology , Protein Transport/drug effects , Protein-Tyrosine Kinases/metabolism , Rats
6.
Transgenic Res ; 18(6): 943-51, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19504171

ABSTRACT

Human insulin-like growth factor binding protein-3 (hIGFBP-3) is a multifunctional protein which has high affinity for insulin-like growth factor-I (IGF-I). It combines with IGF-I to form a tertiary complex in circulation, thus regulating the activity of IGF-I. Furthermore, recombinant hIGFBP-3 (rhIGFBP-3) has been found to negatively regulate cell proliferation and induce apoptosis. In this study, we have established an efficient plant bioreactor platform for mass production of rhIGFBP-3. Different expression constructs, driven by the seed-specific phaseolin promoter, were designed and transformed into tobacco plant via Agrobacterium. To enhance protein expression level, the signal peptide (SP) and the C-terminal tetrapeptide AFVY of phaseolin were used to direct rhIGFBP-3 to protein storage vacuole (PSV) in tobacco seed for stable accumulation. Western blot analysis showed that rhIGFBP-3 was successfully synthesized in transgenic tobacco seeds, with the highest protein expression of 800 mug/g dry weight. The localization of rhIGFBP-3 in PSV was also evident by confocal immunofluorescence microscopy. Our results indicated that protein sorting sequences could benefit the expression level of rhIGFBP-3 and it is feasible to use plant as "bio-factory" to produce therapeutic recombinant proteins in large quantity.


Subject(s)
Insulin-Like Growth Factor Binding Proteins/genetics , Nicotiana/genetics , Genome, Plant , Humans , Insulin-Like Growth Factor Binding Protein 3 , Insulin-Like Growth Factor Binding Proteins/metabolism , Plants, Genetically Modified/genetics , Protein Sorting Signals , Protein Transport , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Rhizobium/genetics , Nicotiana/metabolism , Transformation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...